Yahoo India Web Search

Search results

1. in.linkedin.com › in › milind-sagar-b6548129Milind Sagar - Senior Research Scientist - Syngene ...

   in.linkedin.com › in › milind-sagar-b6548129

   About. * Research exp. in Preclinical research in various R&D and CRO based Pharmaceutical companies. * Experience of developing New lab setup for In-vivo oncology. * Experience in In-vitro and...

   • Senior Resident Surgeon

     View Milind Sagar’s profile on LinkedIn, a professional...

   • LinkedIn India

     Milind Sagar. Data Analyst || Sql analyst || Python...

2. Videos

   • 

     1:30

     youtube.com

     Sukoon (Official Video) - Milind Sagar

     15 Apr 2022

     2.9K views

   • 

     5:38

     youtube.com

     Jaaneman

     2 Jun 2016

     9.2K views

   • 

     4:30

     youtube.com

     Chimpui love song. ..............

     31 Jan 2019

     2.8K views

   View all

3. www.researchgate.net › profile › Milind-SagarMilind SAGAR | Associate Scientist | M.Tech. | Syngene ...

   www.researchgate.net › profile › Milind-Sagar

   Milind SAGAR, Associate Scientist | Cited by 75 | of Syngene International Ltd., Bengaluru | Read 7 publications | Contact Milind SAGAR

4. www.youtube.com › watchSukoon (Official Video) - Milind Sagar - YouTube

   www.youtube.com › watch

   • Cached

   © 2024 Google LLC. 🎧 Listen to "SUKOON” Spotify - https://open.spotify.com/album/5664NXwmxlOLvgteFTxy4OGaana - https://gaana.com/song/sukoon-58Jio Savan - https://www.jiosaav...

   • Video Duration: 2 min
   • Views: 2.9K

   • Author: Milind sagar

5. Images

   • 
   • 
   • 
   • 
   • 

   View all

6. orcid.org › 0000/0001/8976-280XMilind Sagar (0000-0001-8976-280X) - ORCID

   orcid.org › 0000/0001/8976-280X

   Milind Sagar (0000-0001-8976-280X) - ORCID. Activities. Collapse all. expand_more. Works (8) sort Sort. BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth. Cancer Research. 2023-06-02 | Journal article. DOI: 10.1158/0008-5472.CAN-21-4425.

7. pubmed.ncbi.nlm.nih.gov › 37074042BCA101 Is a Tumor-Targeted Bifunctional Fusion ... - PubMed

   pubmed.ncbi.nlm.nih.gov › 37074042

   Jun 2, 2023 · BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth. Cancer Res. 2023 Jun 2;83 (11):1883-1904. doi: 10.1158/0008-5472.CAN-21-4425.